PTGS2 and cancer: Indeed, COX-2 inhibitors have been studied for their putative anticancer activity, as they could stimulate antiangiogenic, anti-inflammatory, and proapoptotic mechanisms [97], but data about their role in cancer treatment are still conflicting.